“I see Medical Affairs co-leading the pharmaceutical and MedTech industries into a new era of patient-centered evidence generation and communication in a valued-based world,” Kremer says.
MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations.
The MAPS Patient Centricity FAWG surveyed Medical Affairs community, including MAPS members, for their input on patient centricity initiatives within their respective organizations. We will be sharing insights from the recent MAPS Patient Centricity Survey on industry perspectives, including the major barriers to implementing initiatives that were identified in the survey. Our experts will be providing guidance and potential solutions on addressing major barriers for patient centricity initiatives identified through the survey.
This podcast reviews new ways of identifying and quantifying opportunities for field medical impact with disease-state analytics.
MAPS speaks with Amit Lalwani, omnichannel lead and member of the Core Planning Team for the MAPA/MAPS Medical Affairs Summit, Nov 8-10, 2023 in Sydney, AU.
Kesselring will work with the MAPS Professional Development Committee to assist with the creation of courses supporting 7 Medical Affairs competency certification tracks identified in the MAPS 5-year strategic plan.
With continuing changes in where HCPs are going for information, Medical Affairs has to be flexible and ensure our content is reaching our audiences. This often requires approval of a novel channel for Medical Affairs, but gaining internal compliance approvals can be challenging. This webinar will focus on practical ways to optimize your partnerships with compliance to ensure successful approval and launch of novel channels.
This white paper addresses insights challenges in Strategy, Data Generation, and Analysis/Reporting – arming Medical Affairs teams with the tools and opportunity to build strategies that preempt these challenges.
The question on the minds of Medical Affairs: What should I know about generative Artificial Intelligence (AI) and its impact on my organization? Fueled by the rapid growth of ChatGPT, generative AI is the news topic of the year – creating a sense of urgency to understand and apply it in our day-to-day workflow against a backdrop of compliance and security concerns.
But there’s good news – generative AI can support Medical Affairs by reducing the analyzing and reporting time required by an ever-growing number of channels and a mountain of data. In the quest to separate signal from noise, generative AI has real potential – now – to cut workloads, provide more accurate insights, and add a competitive edge to teams who apply it across insight-gathering activities.
In this webinar, join industry and AI experts to:
The combined impact of treatment complexity and data availability highlights the value of Medical Affairs departments that have the capability to make clinical sense of new disruptive drugs, devices, real-time monitoring and diagnostics. Here, the MAPS Executive Consortium describes how.